Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-05-01T06:06:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-23T22:59:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed study objectives and inclusion/exclusion criteria for a clinical trial on quizartinib for AML, which are now absent. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    23%
    Check dated 2025-04-16T17:23:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T12:51:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:51:42.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:36:05.000Z thumbnail image

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.